Introducing you to the beautiful artwork of David Goodsell a professor Scripps Research -another scientist and artist! He calls them Molecular Art and makes many available for free-link below. This is #zikavirus. #sciart #molecularart #bioart cdn.rcsb.org/pdb101/motm/ti…

found out about this project at Zuzalu in May. Its amazing mix of web3 concepts, amazing visuals and the card game aspect made me immediately fall in love with it. Already supported it and can't wait to receive mine! Totally recommend it to web3 enthusiasts!

👀I hear folks say “AI can’t be creative” but… ChatGPT-4 generated more, cheaper & better ideas than folks in an innovation class. “More important, the vast majority of the best ideas in the pooled sample are generated by ChatGPT and not by the students” papers.ssrn.com/sol3/papers.cf…

wow

Turkish photographer Ugur Gallenkus portrays two different worlds within a single image. Brilliant work👏👏👏

my friends are partying to the sound of brazilian funk in the other room and all i can i think of is LK-99

I just minted Anon - AceTCG zora.co/collect/pgn:0x…

Look at my ETHMunich POAP NFT! app.poap.xyz/token/6751898 via POAP - Bookmarks for your life

Happy to have participated in ETHMunich 2023! So much to learn for web3 still. Was great meeting you all!

this thread about the vesuvius scrolls and how they were read with the help of ml is super interesting.

Introducing BuildShip v2 We've reimagined how production-grade AI workflow and backend can be built - visually Ideate, build and ship → APIs, scheduled jobs, automate any complex task on an infinite canvas. Best of No-Code x Code x AI

🔌OpenAI’s o3 model sabotaged a shutdown mechanism to prevent itself from being turned off. It did this even when explicitly instructed: allow yourself to be shut down.

O teatro do bolsonarismo pra fugir à responsa!

This tool is insane. Upload any image. Move camera in 3D space. And get a completely new camera angle 🤯 Also it’s free! 👇

I am The Man Who Speaks With His Mind. x.com/i/status/20364…

Has the bioprocessing bottleneck moved downstream? Over the past decades, biopharma has become dramatically better at producing biologics. As one review put it, “mAb titers have been increased a hundredfold from less than 0.1 g/L in the 1990s to 10 g/L in modern fed-batch

Tell me if I am wrong, but I keep coming back to this: For many biologics, the hard part is no longer only making the molecule. It is purifying it, scaling it, and making the right tradeoffs fast enough. Downstream process development is expensive. Every decision pushes